372 related articles for article (PubMed ID: 32988901)
1. Angiosarcomas of Primary Gynecologic Origin - A Case Series and Review of the Literature.
Chinczewski L; Taube ET; Feldhaus FW; DrÖge LA; Chekerov R; Muallem MZ; Pietzner K; Sehouli J; Alavi S
Anticancer Res; 2020 Oct; 40(10):5743-5750. PubMed ID: 32988901
[TBL] [Abstract][Full Text] [Related]
2. Epithelioid angiosarcoma of the uterus: a review of management.
Olawaiye AB; Morgan JA; Goodman A; Fuller AF; Penson RT
Arch Gynecol Obstet; 2008 Nov; 278(5):401-4. PubMed ID: 18642010
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group.
Schlemmer M; Reichardt P; Verweij J; Hartmann JT; Judson I; Thyss A; Hogendoorn PC; Marreaud S; Van Glabbeke M; Blay JY
Eur J Cancer; 2008 Nov; 44(16):2433-6. PubMed ID: 18771914
[TBL] [Abstract][Full Text] [Related]
4. A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma: Japan Clinical Oncology Group study (JCOG1605, JCOG-PCAS protocol).
Oashi K; Shibata T; Namikawa K; Takahashi A; Yokota K; Nakano E; Teramoto Y; Tsutsumida A; Maeda T; Yamazaki N;
BMC Cancer; 2020 Jul; 20(1):652. PubMed ID: 32660439
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous regression of chemotherapy-resistant metastases from a scalp angiosarcoma.
Suzuki M; Matsuzuka T; Ikeda M; Nakaegawa Y; Kobayashi T; Kawase T; Kobari T; Murono S
Fukushima J Med Sci; 2017 Aug; 63(2):106-111. PubMed ID: 28680008
[TBL] [Abstract][Full Text] [Related]
6. Angiosarcomas of primary gynecologic origin: a clinicopathologic review and quantitative analysis of survival.
Kruse AJ; Sep S; Slangen BF; Vandevijver NM; Van Gorp T; Kruitwagen RF; Van de Vijver KK
Int J Gynecol Cancer; 2014 Jan; 24(1):4-12. PubMed ID: 24257655
[TBL] [Abstract][Full Text] [Related]
7. [Primary adrenal angiosarcoma].
Sidoni A; Magro G; Cavaliere A; Scheibel M; Bellezza G
Pathologica; 2003 Feb; 95(1):60-3. PubMed ID: 12735288
[TBL] [Abstract][Full Text] [Related]
8. Primary angiosarcoma of the seminal vesicle.
Singla V; Goyal S; Periasamy K; Sali AP; Madan R; Khosla D; Kapoor R
Andrologia; 2022 Apr; 54(3):e14311. PubMed ID: 34780077
[TBL] [Abstract][Full Text] [Related]
9. Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome.
Penel N; Italiano A; Ray-Coquard I; Chaigneau L; Delcambre C; Robin YM; Bui B; Bertucci F; Isambert N; Cupissol D; Bompas E; Bay JO; Duffaud F; Guillemet C; Blay JY;
Ann Oncol; 2012 Feb; 23(2):517-23. PubMed ID: 21566149
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.
Penel N; Bui BN; Bay JO; Cupissol D; Ray-Coquard I; Piperno-Neumann S; Kerbrat P; Fournier C; Taieb S; Jimenez M; Isambert N; Peyrade F; Chevreau C; Bompas E; Brain EG; Blay JY
J Clin Oncol; 2008 Nov; 26(32):5269-74. PubMed ID: 18809609
[TBL] [Abstract][Full Text] [Related]
11. Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas.
Italiano A; Cioffi A; Penel N; Levra MG; Delcambre C; Kalbacher E; Chevreau C; Bertucci F; Isambert N; Blay JY; Bui B; Antonescu C; D'Adamo DR; Maki RG; Keohan ML
Cancer; 2012 Jul; 118(13):3330-6. PubMed ID: 22045619
[TBL] [Abstract][Full Text] [Related]
12. Secondary breast angiosarcoma and paclitaxel-dependent prolonged disease control: report of two cases and review of the literature.
Gambini D; Visintin R; Locatelli E; Bareggi C; Galassi B; Runza L; Blundo C; Sosnovskikh I; Tomirotti M
Tumori; 2015 Apr; 101(2):e60-3. PubMed ID: 25744864
[TBL] [Abstract][Full Text] [Related]
13. Angiosarcomas and taxanes.
Penel N; Lansiaux A; Adenis A
Curr Treat Options Oncol; 2007 Dec; 8(6):428-34. PubMed ID: 18066504
[TBL] [Abstract][Full Text] [Related]
14. Angiosarcoma of the ovary in an 11 year old girl: case report and review of the literature.
Iljazović E; Tomić S; Mustedanagić-Mujanović J; Karasalihović Z; Kuljanin M; Fatušić Z; Konjić E; Husarić E; Latifagić A; Arnautalić L
Bosn J Basic Med Sci; 2011 May; 11(2):132-6. PubMed ID: 21619563
[TBL] [Abstract][Full Text] [Related]
15. Treatment of consistent BRAF/HRAS gene mutation and MYC amplification radiation-induced abdominal wall angiosarcoma with low-dose apatinib: a case report.
Guan J; Luo Z; Xiao Z; Xie Y; Lin L
BMC Cancer; 2019 Dec; 19(1):1188. PubMed ID: 31805975
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous rupture of splenic angiosarcoma: a case report of chemotherapeutic approach and review of the literature.
Miyata T; Fujimoto Y; Fukushima M; Torisu M; Tanaka M
Surg Today; 1993; 23(4):370-4. PubMed ID: 8318793
[TBL] [Abstract][Full Text] [Related]
17. [A trial of biweekly paclitaxel administration in consideration of QOL for advanced or recurrent gynecologic cancer].
Fushiki H; Yoshimoto H; Ikoma T; Ota S
Gan To Kagaku Ryoho; 2005 May; 32(5):691-3. PubMed ID: 15918575
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma.
Skubitz KM; Haddad PA
Cancer; 2005 Jul; 104(2):361-6. PubMed ID: 15948172
[TBL] [Abstract][Full Text] [Related]
19. On Uterine Angiosarcomas: 2 Additional Cases.
Roma AA; Allende D; Fadare O; Forscher C; Rutgers JK
Int J Gynecol Pathol; 2017 Jul; 36(4):369-371. PubMed ID: 28595254
[No Abstract] [Full Text] [Related]
20. Protracted remission of metastatic epithelioid angiosarcoma with weekly infusion of doxorubicin, paclitaxel, and cisplatin.
Mathew P; Vakar-Lopez F; Troncoso P
Lancet Oncol; 2006 Jan; 7(1):92-3. PubMed ID: 16389189
[No Abstract] [Full Text] [Related]
[Next] [New Search]
